The new PDUFA bill might not be strong enough to overcome the weaknesses of the current system of post-marketing surveillance of new drugs.
You are here
P&T® Journal contents for June 2007
Letters to the Editor
Health Care & Law
At one time, the “War on Drugs” centered on illicit, addictive agents. This article addresses the growing misuse of “legitimate” prescription drugs.
The author discusses the biology and etiology of lymphoma, genetic factors, standard chemotherapy, novel antibody therapy, clinical trials, and adverse drug effects.
Studies presented at the meeting focused on agents for acute coronary syndrome and carotid artery intima media thickness; optimal medical therapy with or without percutaneous coronary intervention; and a thrombin receptor agonist designed to reduce clinical events without increasing bleeding.
Continuing Education Credit
The author reviews the etiology and stages of non-inflammatory and inflammatory manifestations of acne along with various therapies, including topical and oral antibiotics and retinoids; hormones; and nutritional supplements.